Ad is loading...
GAFFX
Price
$80.09
Change
-$1.35 (-1.66%)
Updated
Nov 15 closing price
MFEIX
Price
$221.66
Change
-$4.93 (-2.18%)
Updated
Nov 15 closing price
Ad is loading...

GAFFX vs MFEIX

Header iconGAFFX vs MFEIX Comparison
Open Charts GAFFX vs MFEIXBanner chart's image
American Funds Growth Fund of Amer F3
Price$80.09
Change-$1.35 (-1.66%)
VolumeN/A
CapitalizationN/A
MFS Growth I
Price$221.66
Change-$4.93 (-2.18%)
VolumeN/A
CapitalizationN/A
GAFFX vs MFEIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. MFEIX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and MFEIX is a Buy.

FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 298B vs. MFEIX (47B). GAFFX pays higher dividends than MFEIX: GAFFX (0.75) vs MFEIX (0.00). GAFFX was incepted earlier than MFEIX: GAFFX (8 years) vs MFEIX (28 years). GAFFX is a more actively managed with annual turnover of: 31.00 vs. MFEIX (25.00). MFEIX has a lower initial minimum investment than GAFFX: MFEIX (0) vs GAFFX (1000000). GAFFX (28.41) and MFEIX (28.07) have marching annual gain over last year. MFEIX return over 5 years is better than : 79.32 vs. GAFFX (54.44).
GAFFXMFEIXGAFFX / MFEIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years28 years-
Gain YTD26.82528.93093%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets298B47B634%
Annual Yield % from dividends0.750.00-
Returns for 1 year28.4128.07101%
Returns for 3 years-3.789.15-41%
Returns for 5 years54.4479.3269%
Returns for 10 yearsN/A201.81-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RGA231.952.44
+1.06%
Reinsurance Group of America
FL23.60-0.15
-0.63%
Foot Locker
EDSA2.10-0.10
-4.55%
Edesa Biotech
EVER17.80-1.01
-5.37%
EverQuote
ADVM6.86-0.39
-5.38%
Adverum Biotechnologies